Skip to main content

Table 1 Virus isolates used in this study

From: Immunological characteristics of MAV/06 strain of varicella-zoster virus vaccine in an animal model

Strain name

Strain origin

Clade

Sampling date

Patient information

(Sex, Age)

Accession No

References

YC01

Zoster

2

19 June 2012

M, 40

KJ767491.1

Kim et al. [27]

YC02

Zoster

2

18 July 2012

M, 3

KJ767492.1

Kim et al. [27]

YC03

Zoster

2

07 Aug. 2012

F, 8

KJ808816.1

Kim et al. [27]

YC04

Zoster

2

02 May 2013

F, 76

Kim et al. [27]

YC05

Zoster

2

01 July 2013

F, 52

Kim et al. [27]

YC06

Zoster

2

09 July 2013

M, 73

Kim et al. [27]

YC07

Zoster

2

22 July 2013

M, 80

Kim et al. [27]

YC08

Zoster

2

24 July 2013

M, 66

Kim et al. [27]

Jena 4 (432/2008)

Zoster

1

07 Feb.2008

M, 57

JN704695.1

Sauerbrei et al. [31]

Jena 6 (1883/2007)

Varicella

1

07 Nov.2007

F, 4

JN704694.1

Sauerbrei et al. [31]

Jena 12 (2308/2003)

Varicella

3

22 Nov.2003

F, 5

JN704699.1

Sauerbrei et al. [31]

Jena 16 (52/2007)

Zoster

3

08 Jan.2007

M, 18

JN704701.1

Sauerbrei et al. [31]

Jena 26 (446/2007)

Varicella

5

15 Mar.2007

M, 1

JN704707.1

Sauerbrei et al. [31]

MAV/06

Varicella

2

1989

M, 3

JF306641.2

Lee et al. (2011)

  1. To demonstrate the cross-reactivity, various strains of wild type VZV were used along with an attenuated type VZV, MAV/06